Maxlinear (MXL) Cash & Equivalents (2010 - 2026)

Maxlinear (MXL) has reported Cash & Equivalents for 17 consecutive years, with $64.8 million the latest figure, recorded in Q2 2026.

• In Q2 2026, Cash & Equivalents fell 40.33% year-over-year to $64.8 million; the TTM figure through Jun 2026 stood at $64.8 million (down 40.33% YoY), while the FY2025 annual figure was $72.8 million, down 38.6% from the prior year.
• Cash & Equivalents improved to $64.8 million in Q2 2026 per MXL's latest filing, from $61.1 million in the prior quarter.
• Across five years, Cash & Equivalents topped out at $224.6 million in Q2 2023 and bottomed at $61.1 million in Q1 2026.
• Historically, Cash & Equivalents has averaged $150.2 million across 5 years, with a median of $166.3 million in 2022.
• Annual changes were most pronounced in 2022 — Cash & Equivalents jumped 62.2% — and 2025, when it slumped 46.44%.
• Maxlinear's Cash & Equivalents stood at $187.4 million in 2022, then slipped by 0.03% to $187.3 million in 2023, then plunged by 36.69% to $118.6 million in 2024, then tumbled by 38.6% to $72.8 million in 2025, then decreased by 10.98% to $64.8 million in 2026.
• Business Quant data shows MXL's Cash & Equivalents at $64.8 million in Q2 2026, $61.1 million in Q1 2026, and $72.8 million in Q4 2025.